Pas de connexion internet — affichage de la version enregistrée de la page.

Inovio Pharmaceut…

USUSD
← Vers le Screener
US:INOLSE:0A43

Inovio Pharmaceuticals Inc (US:INO) — Biotechnology: Pharmaceutical Preparations. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site Web
inovio.com
Relations avec les Investisseurs
ir.inovio.com/overview/default.aspx
Secteur
Health Care · Biotechnology: Pharmaceutical Preparations
Siège Social
PLYMOUTH MEETING, United States
PDG
Jacqueline E. Shea
Employés
112
Actions en Circulation
103.4 M au 2026-08-10
Flottant
95.79 M
Capitalisation Boursière
118.91 M USD
Initiés
0.33%
Investisseurs Institutionnels
46.06%
Secteur d'Activité (SIC)
Pharmaceutical Preparations
P/E
perte
FCF
−80.8 M USD
Dette
62.8 M USD
Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
Description

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company's lead product candidate is INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade squamous intraepithelial lesions; INO-3112 for the treatment of HPV-related Oropharyngeal squamous cell carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 2/3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. The company's partners and collaborators ApolloBio Corporation, AstraZeneca, Coherus Biosciences, Defense Advanced Research Projects Agency, HIV Vaccines Trial Network, Kaneka Eurogentec, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the University of Pennsylvania, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

publicité

Bourses et Tickers

BourseTickerDevisePrixType
US USA StocksINO principaleUSD0.9982 -9.67%actions ordinaires
LSE London Stock Exchange0A43 IOBUSD1.1919 +0.00%actions ordinaires

Cours sur 3 Mois

jour de hausse jour de baisseSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Principaux Actionnaires

DétenteurParticipationActionsDate du Rapport
FMR, LLC8.18%8.45 M2026-06-30
Fidelity Securities Fund…6.76%6.99 M2026-07-31
Jupiter Topco LLC5%5.17 M2026-06-30
Vanguard Capital Managem…3.53%3.65 M2026-06-30
Fidelity Securities Fund…3.42%3.54 M2026-07-31
Boxer Capital Management…2.75%2.84 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.51%2.6 M2026-06-30
Adar1 Capital Management…2.07%2.14 M2026-06-30
Shaw D.E. & Co., Inc.1.31%1.35 M2026-06-30
Two Sigma Investments, L…1.2%1.24 M2026-06-30
Eversept Partners, LP1%1.04 M2026-06-30
VANGUARD INDEX FUNDS-Van…0.93%963 3252026-06-30
Geode Capital Management…0.78%802 7512026-06-30
Millennium Management Ll…0.77%796 1072026-06-30
Fidelity Concord Street…0.39%398 4002026-07-31
iShares Trust-iShares Mi…0.27%278 2952026-08-31
Bridgeway Funds, Inc.-Ul…0.17%173 0002026-06-30
SHEA JACQUELINE ELIZABET…≈0.11%111 0212026-05-20
Fidelity Concord Street…0.1%104 0052026-07-31
Fidelity Concord Street…0.09%96 1192026-07-31
WEINER DAVID B (Director…≈0.08%87 5922026-02-26
Invesco Exch-Trd Fd. TRT…0.08%85 2652026-08-31
HUMEAU LAURENT M (Office…≈0.05%46 8232026-05-20
KIES PETER D (Chief Fina…≈0.04%43 2292026-05-20
SUMNER MICHAEL JOHN (Off…≈0.04%42 0382026-05-20
BENITO SIMON X (Director…≈0.01%12 1912025-05-21
YARNO WENDY L (Director)≈0.01%10 5122025-05-21
MILLER ANN CALBY M.D. (D…≈0.01%9 8772025-05-21
SHEPARD JAY P. (Director…≈0.01%9 2092025-05-21
DANSEY ROGER D (Director…≈0.01%8 9162025-05-21